Wedge Capital Management L L P NC Sells 61,707 Shares of DaVita Inc. (NYSE:DVA)

Wedge Capital Management L L P NC cut its stake in shares of DaVita Inc. (NYSE:DVA) by 18.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 272,524 shares of the company’s stock after selling 61,707 shares during the quarter. Wedge Capital Management L L P NC owned approximately 0.31% of DaVita worth $37,764,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in DaVita by 2.4% during the 4th quarter. Vanguard Group Inc. now owns 6,320,740 shares of the company’s stock valued at $662,161,000 after purchasing an additional 145,711 shares in the last quarter. Gates Capital Management Inc. increased its stake in shares of DaVita by 3.1% in the fourth quarter. Gates Capital Management Inc. now owns 905,830 shares of the company’s stock valued at $94,895,000 after buying an additional 27,660 shares in the last quarter. 8 Knots Management LLC bought a new position in shares of DaVita in the fourth quarter valued at about $89,504,000. Allianz Asset Management GmbH lifted its position in DaVita by 63.9% during the 4th quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock worth $57,476,000 after buying an additional 213,992 shares in the last quarter. Finally, Doma Perpetual Capital Management LLC bought a new stake in DaVita during the 4th quarter worth about $53,076,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on DVA shares. UBS Group upped their target price on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. TD Cowen increased their price objective on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Barclays boosted their target price on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Monday, May 6th. StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. Finally, Truist Financial boosted their price objective on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $154.00.

Insider Transactions at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now directly owns 83,011 shares in the company, valued at approximately $12,137,038.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is currently owned by insiders.

DaVita Trading Up 0.7 %

Shares of NYSE:DVA traded up $1.07 during midday trading on Thursday, hitting $149.95. The company had a trading volume of 933,252 shares, compared to its average volume of 839,733. The firm has a fifty day simple moving average of $140.17 and a 200 day simple moving average of $134.47. The stock has a market cap of $13.15 billion, a price-to-earnings ratio of 17.04, a PEG ratio of 0.81 and a beta of 0.87. The company has a current ratio of 1.16, a quick ratio of 1.12 and a debt-to-equity ratio of 9.94. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $151.55.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.47 by $0.12. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company earned $2.08 EPS. On average, analysts predict that DaVita Inc. will post 9.9 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.